Posts by isp_developer
Finally, an on-demand source of mutation characterized tumor FFPE tissue samples
Precision medicine demands precision research. In other words, researchers require very specific human biospecimens to develop new techniques, tests, diagnostics, and treatments. Sadly, such samples are in sparse supply and finding them can be quite challenging and painful. Supply comes nowhere close to meeting demand. Genetic signatures are the quintessence of specificity in human biospecimens…
Read MoreWhen planning a research project, strike before the iron is hot
When you need human biospecimens for research, we will help source them as quickly as possible. But here is a secret to getting them even earlier: contact us for help before you need your biospecimens. Well before. If you do, we will streamline the procurement process and develop a solid request for proposals (RFP) that…
Read MoreA Data-Driven Journey to “Just-in-Time” Biobanking
A Prime Catalyst for Evolving Biobanking Strategies Changes in the life sciences industry are creating challenges for biobanks, making their ability to evolve imperative to their success in the future. More specifically, the proliferation of precision medicine and regenerative medicine further underscores the need for highly customized biospecimen collections. Applications such as companion diagnostic development,…
Read MoreStreamlining biospecimen sharing and sourcing
iSpecimen Marketplace® helps life science researchers in industry, government, and academia streamline the procurement of human biospecimens for their upstream research and work on treatments and diagnostics. The Marketplace also facilitates the sharing of specimens through our global network of biospecimen suppliers—including hospitals, labs, biobanks, and blood centers—by providing human biofluids, tissue, and cells for…
Read MorePlastic is everywhere, including our bloodstreams
Plastics are ubiquitous in the developed world, and scientists have long known that humans breathe and inadvertently eat microscopic fragments – equivalent, by one account, to a credit card’s worth plastic every week. Now, for the first time, Dutch researchers have proved micro- and nanoplastic particles from the environment end up in the human bloodstream. It’s the latest discovery affirming the importance of human biospecimens in advancing medical progress.
Read MoreBeauty and immunity: natural bedfellows
Looks do matter, at least when it comes to immune system performance, suggests a new study.
Read MoreA case study in finding cost effective FFPE blocks
Some of the best values are hidden in plain sight, like Toyotas, index funds and refurbished electronics. The same is true in the biospecimen world. Let us walk you through it. We’re known by many clients for giving researchers access to millions of banked and clinical remnant samples through our online platform, the iSpecimen Marketplace,…
Read MoreSoon, perhaps, a blood test for long COVID
Why do roughly 1 in 3 COVID-19 patients experience symptoms lasting a month or more? And which newly diagnosed patients will develop so-called “long COVID”? Researchers may be approaching answers with the discovery that reduced levels of certain antibodies in the blood may help predict who will suffer long COVID.
Read MoreiSpecimen expands fight against covid-19
As the pandemic continues to rear its ugly head this winter, we have strengthened our fight against the disease by expanding our supplier network with the addition of a new reference lab in New York to support commercial and government customers focused on COVID-19 research involving the Omicron and Delta variants. The reference lab has…
Read MoreAI-assisted liquid biopsy shows results on lung cancer
Lung cancer is a leading cause of cancer death, making up nearly 25% of all cancer deaths (not all of which are smoking-related), but only 5% to 6% of at-risk Americans undergo recommended CT screening, with many concerned about radiation exposure and invasive procedures.
Read More